[ET Net News Agency, 13 February 2020] A newswire reported that there are talks of
China Life Group plans to list its key businesses in Hong Kong as early as this year by
injecting key assets into its listed China Life Insurance (02628), which will issue new
shares to the parent company.
Nomura thinks the most important assets, which have not been injected into the listed
company, include China Life P&C (60% held by Group) and China Life Overseas (100% held by
Group). The research house thinks their value may be relatively small compared to the
the market cap of the listed company, at 1.6%/4.1%, respectively.
Nomura maintained its "buy" call on China Life, with a target price of HK$25.14. (KL)
|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02628 CHINA LIFE
Nominal 
9.000 -0.060 (-0.662%) Research Report
13/02/2020 17:56
{I-bank focus}China Life parent's key assets small - Nomua
| Remark: | Real time quote last updated: 19/04/2024 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service |